KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Payables (2016 - 2025)

Globus Medical (GMED) has disclosed Payables for 15 consecutive years, with $98.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Payables rose 31.6% year-over-year to $98.9 million, compared with a TTM value of $98.9 million through Dec 2025, up 31.6%, and an annual FY2025 reading of $98.9 million, up 31.6% over the prior year.
  • Payables was $98.9 million for Q4 2025 at Globus Medical, up from $87.2 million in the prior quarter.
  • Across five years, Payables topped out at $98.9 million in Q4 2025 and bottomed at $2.2 million in Q4 2021.
  • Average Payables over 5 years is $49.9 million, with a median of $45.2 million recorded in 2023.
  • The sharpest move saw Payables crashed 87.92% in 2021, then soared 1540.95% in 2022.
  • Year by year, Payables stood at $2.2 million in 2021, then skyrocketed by 1540.95% to $36.1 million in 2022, then surged by 56.98% to $56.7 million in 2023, then soared by 32.55% to $75.1 million in 2024, then surged by 31.6% to $98.9 million in 2025.
  • Business Quant data shows Payables for GMED at $98.9 million in Q4 2025, $87.2 million in Q3 2025, and $87.1 million in Q2 2025.